Skip to main content
. 2021 Feb 1;26(6):e925–e935. doi: 10.1002/onco.13668
Generic/Working Name Apatinib
Company Name Hengrui Company
Drug Type Small molecule
Drug Class VEGFR
Dose 500 milligrams (mg) per flat dose
Route Oral (p.o.)
Schedule of Administration All patients received continuous apatinib 500 mg once daily until disease progression, death, intolerable toxicity, or patient request for withdrawal from the study occurred. Dose escalation was allowed. The dose decreased to 250 mg in patients who had grade 3 or higher adverse events.